Pathway-Specific Remodeling of Thalamostriatal Synapses in Parkinsonian Mice

Neuron

Volumn 89, Issue 4, 2016, Pages 734-740

  Parker, Philip R L ^a,b   Lalive, Arnaud L ^b   Kreitzer, Anatol C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GLADSTONE INSTITUTES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMINO ACID RECEPTOR STIMULATING AGENT; EMPTY SPIRACLES HOMEOBOX PROTEINS; HOMEODOMAIN PROTEIN; N METHYLASPARTIC ACID; OXIDOPAMINE; SLC17A6 PROTEIN, MOUSE; TRANSCRIPTION FACTOR; TYROSINE 3 MONOOXYGENASE; VESICULAR GLUTAMATE TRANSPORTER 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN SLICE; CONTROLLED STUDY; DRUG TARGETING; IN VIVO STUDY; MOTOR DYSFUNCTION; MOUSE; NERVE CELL STIMULATION; NERVE ENDING; NERVE PROJECTION; NONHUMAN; OPTOGENETICS; PARKINSONISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEPLETION; SENSORIMOTOR CORTEX; STRIATE CORTEX; SYNAPTIC TRANSMISSION; THALAMUS; WHOLE CELL PATCH CLAMP; ANIMAL; CHEMICALLY INDUCED; CORPUS STRIATUM; DISEASE MODEL; DRUG EFFECTS; EXCITATORY POSTSYNAPTIC POTENTIAL; EXPLORATORY BEHAVIOR; GENETICS; HEMISPHERIC DOMINANCE; INJURIES; MEDIAL FOREBRAIN BUNDLE; METABOLISM; NERVE TRACT; PATHOLOGY; PHYSIOLOGY; SYNAPSE;

ADRENERGIC AGENTS; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID AGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; EXPLORATORY BEHAVIOR; FUNCTIONAL LATERALITY; HOMEODOMAIN PROTEINS; MEDIAL FOREBRAIN BUNDLE; MICE; N-METHYLASPARTATE; NEURAL PATHWAYS; OXIDOPAMINE; PARKINSONIAN DISORDERS; SYNAPSES; THALAMUS; TRANSCRIPTION FACTORS; TYROSINE 3-MONOOXYGENASE; VESICULAR GLUTAMATE TRANSPORT PROTEIN 2;

EID: 84958213338     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2015.12.038     Document Type: Article

References (33)

1. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989, 12:366-375. 10.1016/0166-2236(89)90074-X.
2. Caparros-Lefebvre D., Blond S., Feltin M.P., Pollak P., Benabid A.L. Improvement of levodopa induced dyskinesias by thalamic deep brain stimulation is related to slight variation in electrode placement: possible involvement of the centre median and parafascicularis complex. J. Neurol. Neurosurg. Psychiatry 1999, 67:308-314. 10.1136/jnnp.67.3.308.
3. Chen C.H., Fremont R., Arteaga-Bracho E.E., Khodakhah K. Short latency cerebellar modulation of the basal ganglia. Nat. Neurosci. 2014, 17:1767-1775. 10.1038/nn.3868.
4. Day M., Wang Z., Ding J., An X., Ingham C.A., Shering A.F., Wokosin D., Ilijic E., Sun Z., Sampson A.R., et al. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat. Neurosci. 2006, 9:251-259.
5. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 1990, 13:281-285. 10.1016/0166-2236(90)90110-V.
6. Ehringer H., Hornykiewicz O. [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system]. Klin. Wochenschr. 1960, 38:1236-1239. 10.1007/BF01485901.
7. Ellender T.J., Harwood J., Kosillo P., Capogna M., Bolam J.P. Heterogeneous properties of central lateral and parafascicular thalamic synapses in the striatum. J. Physiol. 2013, 591:257-272. 10.1113/jphysiol.2012.245233.
8. Ferguson S.M., Eskenazi D., Ishikawa M., Wanat M.J., Phillips P.E.M., Dong Y., Roth B.L., Neumaier J.F. Transient neuronal inhibition reveals opposing roles of indirect and direct pathways in sensitization. Nat. Neurosci. 2011, 14:22-24. 10.1038/nn.2703.
9. Fieblinger T., Graves S.M., Sebel L.E., Alcacer C., Plotkin J.L., Gertler T.S., Chan C.S., Heiman M., Greengard P., Cenci M.A., Surmeier D.J. Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia. Nat. Commun. 2014, 5. 10.1038/ncomms6316.
10. Fremeau R.T., Troyer M.D., Pahner I., Nygaard G.O., Tran C.H., Reimer R.J., Bellocchio E.E., Fortin D., Storm-Mathisen J., Edwards R.H. The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron 2001, 31:247-260. 10.1016/S0896-6273(01)00344-0.
11. Fujiyama F., Furuta T., Kaneko T. Immunocytochemical localization of candidates for vesicular glutamate transporters in the rat cerebral cortex. J. Comp. Neurol. 2001, 435:379-387.
12. Henderson J.M., Schleimer S.B., Allbutt H., Dabholkar V., Abela D., Jovic J., Quinlivan M. Behavioural effects of parafascicular thalamic lesions in an animal model of parkinsonism. Behav. Brain Res. 2005, 162:222-232. 10.1016/j.bbr.2005.03.017.
13. Herzog E., Bellenchi G.C., Gras C., Bernard V., Ravassard P., Bedet C., Gasnier B., Giros B., El Mestikawy S. The existence of a second vesicular glutamate transporter specifies subpopulations of glutamatergic neurons. J. Neurosci. 2001, 21:RC181.
14. Jouve L., Salin P., Melon C., Kerkerian-Le Goff L. Deep brain stimulation of the center median-parafascicular complex of the thalamus has efficient anti-parkinsonian action associated with widespread cellular responses in the basal ganglia network in a rat model of Parkinson's disease. J. Neurosci. 2010, 30:9919-9928. 10.1523/JNEUROSCI.1404-10.2010.
15. Kemp J.M., Powell T.P. The termination of fibres from the cerebral cortex and thalamus upon dendritic spines in the caudate nucleus: a study with the Golgi method. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1971, 262:429-439. 10.1098/rstb.1971.0105.
16. Kreitzer A.C., Malenka R.C. Striatal plasticity and basal ganglia circuit function. Neuron 2008, 60:543-554. 10.1016/j.neuron.2008.11.005.
17. Kress G.J., Yamawaki N., Wokosin D.L., Wickersham I.R., Shepherd G.M.G., Surmeier D.J. Convergent cortical innervation of striatal projection neurons. Nat. Neurosci. 2013, 16:665-667. 10.1038/nn.3397.
18. Magnin M., Morel A., Jeanmonod D. Single-unit analysis of the pallidum, thalamus and subthalamic nucleus in parkinsonian patients. Neuroscience 2000, 96:549-564. 10.1016/S0306-4522(99)00583-7.
19. Matsumoto N., Minamimoto T., Graybiel A.M., Kimura M. Neurons in the thalamic CM-Pf complex supply striatal neurons with information about behaviorally significant sensory events. J. Neurophysiol. 2001, 85:960-976.
20. Mattis J., Tye K.M., Ferenczi E.A., Ramakrishnan C., O'Shea D.J., Prakash R., Gunaydin L.A., Hyun M., Fenno L.E., Gradinaru V., et al. Principles for applying optogenetic tools derived from direct comparative analysis of microbial opsins. Nat. Methods 2012, 9:159-172. 10.1038/nmeth.1808.
21. Mazzone P., Stocchi F., Galati S., Insola A., Altibrandi M.G., Modugno N., Tropepi D., Brusa L., Stefani A. Bilateral implantation of centromedian-parafascicularis complex and GPi: A new combination of unconventional targets for deep brain stimulation in severe Parkinson disease. Neuromodulation 2006, 9:221-228. 10.1111/j.1525-1403.2006.00063.x.
22. Minamimoto T., Hori Y., Kimura M. Complementary process to response bias in the centromedian nucleus of the thalamus. Science 2005, 308:1798-1801. 10.1126/science.1109154.
23. Orieux G., Francois C., Féger J., Yelnik J., Vila M., Ruberg M., Agid Y., Hirsch E.C. Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease. Neuroscience 2000, 97:79-88. 10.1016/S0306-4522(00)00011-7.
24. Parr-Brownlie L.C., Poloskey S.L., Bergstrom D.A., Walters J.R. Parafascicular thalamic nucleus activity in a rat model of Parkinson's disease. Exp. Neurol. 2009, 217:269-281. 10.1016/j.expneurol.2009.02.010.
25. Peppe A., Gasbarra A., Stefani A., Chiavalon C., Pierantozzi M., Fermi E., Stanzione P., Caltagirone C., Mazzone P. Deep brain stimulation of CM/PF of thalamus could be the new elective target for tremor in advanced Parkinson's Disease?. Parkinsonism Relat. Disord. 2008, 14:501-504. 10.1016/j.parkreldis.2007.11.005.
26. Quiroz-Padilla M.F., Guillazo-Blanch G., Vale-Martínez A., Martí-Nicolovius M. Excitotoxic lesions of the parafascicular nucleus produce deficits in a socially transmitted food preference. Neurobiol. Learn. Mem. 2006, 86:256-263. 10.1016/j.nlm.2006.03.007.
27. Smith Y., Galvan A., Ellender T.J., Doig N., Villalba R.M., Huerta-Ocampo I., Wichmann T., Bolam J.P. The thalamostriatal system in normal and diseased states. Front. Syst. Neurosci. 2014, 8:5. 10.3389/fnsys.2014.00005.
28. Stefani A., Peppe A., Pierantozzi M., Galati S., Moschella V., Stanzione P., Mazzone P. Multi-target strategy for Parkinsonian patients: the role of deep brain stimulation in the centromedian-parafascicularis complex. Brain Res. Bull. 2009, 78:113-118. 10.1016/j.brainresbull.2008.08.007.
29. Suárez L.M., Solís O., Caramés J.M., Taravini I.R., Solís J.M., Murer M.G., Moratalla R. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice. Biol. Psychiatry 2014, 75:711-722. 10.1016/j.biopsych.2013.05.006.
30. Surmeier D.J., Plotkin J., Shen W. Dopamine and synaptic plasticity in dorsal striatal circuits controlling action selection. Curr. Opin. Neurobiol. 2009, 19:621-628. 10.1016/j.conb.2009.10.003.
31. Wickens J.R., Wilson C.J. Regulation of action-potential firing in spiny neurons of the rat neostriatum in vivo. J. Neurophysiol. 1998, 79:2358-2364.
32. Yan W., Zhang Q.J., Liu J., Wang T., Wang S., Liu X., Chen L., Gui Z.H. The neuronal activity of thalamic parafascicular nucleus is conversely regulated by nigrostriatal pathway and pedunculopontine nucleus in the rat. Brain Res. 2008, 1240:204-212. 10.1016/j.brainres.2008.09.015.
33. Zhang Y., Meredith G.E., Mendoza-Elias N., Rademacher D.J., Tseng K.Y., Steece-Collier K. Aberrant restoration of spines and their synapses in L-DOPA-induced dyskinesia: involvement of corticostriatal but not thalamostriatal synapses. J. Neurosci. 2013, 33:11655-11667. 10.1523/JNEUROSCI.0288-13.2013.